TickerFactsScreenerDevelopers

BIOGEN INC. (BIIB) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2006: $661.38M2007: $659.66M2008: $622.38M2009: $581.89M2010: $759.60M2011: $514.54M2012: $570.70M2013: $602.60M2014: $1.20B2015: $1.31B2016: $2.33B2017: $1.57B2018: $1.22B2019: $2.91B$2.91B
2006Cash & Equivalents (USD)2019
Fiscal YearCash & EquivalentsChange YoY
2019$2.91B+137.9%
2018$1.22B-22.2%
2017$1.57B-32.4%
2016$2.33B+77.9%
2015$1.31B+8.6%
2014$1.20B+100.0%
2013$602.60M+5.6%
2012$570.70M+10.9%
2011$514.54M-32.3%
2010$759.60M+30.5%
2009$581.89M-6.5%
2008$622.38M-5.7%
2007$659.66M-0.3%
2006$661.38M—